On April 15, 2023, after extensive consideration and discussion with the Board of Directors (the “ Board ”) of Mind Medicine (MindMed) Inc. (the “ Company ”), Brigid A. Makes provided notice to the Board of her decision not to stand for re-election at the Company’s 2023 annual general meeting of shareholders (the “ Annual Meeting ”).
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Brigid A. Makes departed as Director at Definium Therapeutics, Inc..
Action
not to stand for re-election
Role
Director
Exact text from the filing
On April 15, 2023, after extensive consideration and discussion with the Board of Directors (the “ Board ”) of Mind Medicine (MindMed) Inc. (the “ Company ”), Brigid A. Makes provided notice to the Board of her decision not to stand for re-election at the Company’s 2023 annual general meeting of shareholders (the “ Annual Meeting ”).
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.